{
    "ticker": "VCYT",
    "name": "Veracyte, Inc.",
    "description": "Veracyte, Inc. is a leading genomic diagnostics company focused on improving patient outcomes through innovative diagnostic solutions. Established in 2013 and headquartered in South San Francisco, California, Veracyte specializes in providing accurate and reliable diagnostic tests that empower physicians and patients to make informed decisions about their healthcare. The company leverages advanced genomic technology to develop tests that help diagnose diseases, including various cancers and other complex conditions. Veracyte's flagship products include the Afirma Gene Expression Classifier, which aids in the diagnosis of thyroid nodules, and the Percepta Genomic Sequencing Classifier, designed for lung cancer patients. By utilizing the power of genomic data, Veracyte aims to reduce unnecessary surgeries and improve the precision of treatment plans. With a commitment to innovation and excellence, Veracyte is dedicated to expanding its portfolio of diagnostic offerings and advancing the field of genomic medicine. The company's mission is to transform patient care through the development of tests that provide clarity and answers, ultimately enhancing the quality of life for patients worldwide.",
    "industry": [
        "Biotechnology",
        "Diagnostics"
    ],
    "headquarters": "South San Francisco, California, USA",
    "founded": "2013",
    "website": "https://www.veracyte.com",
    "ceo": "Bonnie H. Anderson",
    "social_media": {
        "twitter": "https://twitter.com/Veracyte",
        "linkedin": "https://www.linkedin.com/company/veracyte/"
    },
    "investor_relations": "https://ir.veracyte.com",
    "key_executives": [
        {
            "name": "Bonnie H. Anderson",
            "position": "CEO"
        },
        {
            "name": "Graham Dixon",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Tests",
            "products": [
                "Afirma Gene Expression Classifier",
                "Percepta Genomic Sequencing Classifier"
            ]
        }
    ],
    "seo": {
        "meta_title": "Veracyte, Inc. | Genomic Diagnostics and Innovative Solutions",
        "meta_description": "Explore Veracyte, Inc., a leader in genomic diagnostics committed to improving patient outcomes with accurate diagnostic tests.",
        "keywords": [
            "Veracyte",
            "Genomic Diagnostics",
            "Cancer Diagnosis",
            "Afirma",
            "Percepta",
            "Biotechnology"
        ]
    },
    "faq": [
        {
            "question": "What does Veracyte specialize in?",
            "answer": "Veracyte specializes in genomic diagnostics and develops tests to improve disease diagnosis and patient outcomes."
        },
        {
            "question": "Who is the CEO of Veracyte?",
            "answer": "Bonnie H. Anderson is the CEO of Veracyte, Inc."
        },
        {
            "question": "Where is Veracyte headquartered?",
            "answer": "Veracyte is headquartered in South San Francisco, California, USA."
        },
        {
            "question": "What are Veracyte's main products?",
            "answer": "Veracyte's main products include the Afirma Gene Expression Classifier and the Percepta Genomic Sequencing Classifier."
        },
        {
            "question": "When was Veracyte founded?",
            "answer": "Veracyte was founded in 2013."
        }
    ],
    "competitors": [
        "ILMN",
        "GHDX",
        "EXAS"
    ],
    "related_stocks": [
        "AMGN",
        "ABBV",
        "JNJ",
        "MRNA"
    ]
}